DYN
Dyne Therapeutics Inc
NASDAQ: DYN · HEALTHCARE · BIOTECHNOLOGY
$17.41
-4.13% today
Updated 2026-04-29
Market cap
$2.88B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.47
Dividend yield
—
52W range
$8 – $25
Volume
2.2M
Dyne Therapeutics Inc (DYN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-3.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+17.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-8.6%
Last 3 reports
Positive reaction rate
0%
0 of 3 quarters
Largest single-day move
-15.4%
2025-11-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $-0.73 | +5.5% | $16.09 | $15.62 | -2.9% |
| 2025-11-05 | $-0.76 | +9.5% | $21.52 | $18.21 | -15.4% |
| 2025-07-28 | $-0.97 | -3.2% | $9.95 | $9.20 | -7.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.77 | $-0.73 | +5.5% | — | — |
| 2025-09-30 | $-0.84 | $-0.76 | +9.5% | — | — |
| 2025-06-30 | $-0.94 | $-0.97 | -3.2% | — | — |
| 2025-03-31 | $-0.84 | $-1.05 | -25.5% | — | — |
| 2024-12-31 | $-0.91 | $-0.88 | +3.5% | $1.57M | -58.5% |
| 2024-09-30 | $-0.71 | $-0.96 | -35.6% | — | — |
| 2024-06-30 | $-0.72 | $-0.70 | +2.8% | — | — |
| 2024-03-31 | $-0.80 | $-0.81 | -1.3% | — | — |
| 2023-12-31 | $-0.92 | $-1.09 | -18.5% | $3.79M | — |
| 2023-09-30 | $-0.83 | $-0.99 | -19.3% | — | — |
| 2023-06-30 | $-0.81 | $-1.08 | -33.3% | — | — |
Frequently asked questions
Has Dyne Therapeutics Inc beaten earnings estimates?
Dyne Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -3.4% over the last 4 quarters.
How does DYN stock react to earnings?
DYN stock has moved an average of -8.6% in the trading day following earnings over its last 3 reports, with positive reactions in 0% of those quarters.